CAS · 557795-19-4
Product Overview
Sunitinib is a high-purity a-api supplied for industrial and specialty chemical applications. Contact our team for specifications, packaging options and lead times.
Product Specifications
| Appearance | Orange solid powder |
|---|---|
| Purity | 98% min |
| Identification | H-NMR |
| Water | 0.5% max |
| Melting Point | 189-191 °C |
| Total Impurities | 2% max |
Applications
Sunitinib is primarily used as an oral anticancer agent. It functions as a multi-targeted receptor tyrosine kinase inhibitor, used in the treatment of various cancers including renal cell carcinoma, gastrointestinal stromal tumors, and pancreatic neuroendocrine tumors. Sunitinib is also employed in preclinical and clinical research to investigate cancer signaling pathways, tumor angiogenesis, and drug resistance mechanisms.
Benefits
Sunitinib offers targeted inhibition of multiple receptor tyrosine kinases, including VEGFR, PDGFR, and KIT, which helps to suppress tumor growth, angiogenesis, and metastasis. Its oral administration improves patient compliance, and its multi-targeted action increases therapeutic efficacy against diverse tumor types. Additionally, Sunitinib has shown clinical benefits in prolonging progression-free survival and improving overall outcomes in patients with advanced cancers.
Conclusion
Sunitinib is a potent targeted anticancer drug with applications in treating multiple tumor types. Its multi-targeted mechanism and oral bioavailability make it a key therapeutic option in oncology, while its use in research continues to advance understanding of cancer biology and targeted therapy development.
Previous
Ambroxol Hydrochloride丨CAS 23828-92-4
Next